Michael J Lukason

Michael J Lukason

CRISPR Therapeutics - Sydney / Switzerland
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4970553
person_outline Michael J Lukason's MOST POPULAR ARTICLES
1-) CRISPR/Cas9-mediated genome editing as a therapeutic approach for Leber congenital amaurosis 10GX Ruan, E Barry, D Yu, M Lukason, SH Cheng, A ScariaMolecular Therapy 25 (2), 331-341, 20172662017
2-) Safety and efficacy of repetitive adenovirus–mediated transfer of CFTR cDNA to airway epithelia of primates and cotton ratsJ Zabner, DM Petersen, AP Puga, SM Graham, LA Couture, LD Keyes, ...Nature genetics 6 (1), 75-83, 19942651994
3-) Preclinical safety evaluation of AAV2-sFLT01—a gene therapy for age-related macular degeneration TK MacLachlan, M Lukason, M Collins, R Munger, E Isenberger, ... Molecular Therapy 19 (2), 326-334, 2011 1832011
4-) Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularizationP Pechan, H Rubin, M Lukason, J Ardinger, E DuFresne, WW Hauswirth, ...Gene therapy 16 (1), 10-16, 20091762009
5-) Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapyGD Hurlbut, RJ Ziegler, JB Nietupski, JW Foley, LA Woodworth, E Meyers, ...Molecular Therapy 18 (11), 1983-1994, 20101542010